Rhiza Labs FluTracker Forum

Henry Niman, DARPA, MAYA, The MITRE Corporation, and Jeff Rense
Posted by labvirus on February 25, 2011

We already know Henry Niman PhD is an Ashkenazi Kezar. We also know he lives up to his nickname Henry LIEman, as he asserts H1N1 occurred naturally and that the vaccines have efficacy.

Following are some links and excerpts Ive collected to show the relationship between Henry Niman and DARPA, the MITRE Corporation and the work of Taubenberger and Tumpey. Regarding Jeff Rense who exclusively broadcasts LIEman’s crap [carried by RBN], I’ll leave it to you to do your own research and draw your own conclusions.

First, some background:

Henry LIEman is quoted as having said on a public radio broadcast, “Oh, yeah, five swine, three bird and two human flu viruses have been in the swine since 1990′s. It’s natural. It’s NOT MANUFACTURED/ENGINEERED in a lab.”

History of Synthetic H1N1 Flu Virus

When the first reported cases of A/H1N1 swine flu emerged in April 2009, it was widely believed that the novel influenza strain originated in Mexico. By late June, when evidence failed to materialize confirming a Mexican origin, a new theory hypothesized that A/H1N1 originated in Asia and was transported unintentionally via an unsuspecting human carrier to North America. This though, probably is not the case. Instead it is likely, though not confirmed, that A/H1N1, is a genetically engineered creation that originated in the United States, specifically in a lab in Madison, Wisconsin that had accidentally escaped through some kind of contamination.

The evidence for this scenario is compelling:

1. Prior to the A/H1N1 outbreak, The Institute for Molecular Virology (IMV) located in Bock Labs (administered by the University of Wisconsin-Madison) had been involved in a transmission capability study for vaccine production. This study involved reverse genetic engineering of a tissue specimen that had been extracted from a deceased Intuit woman who had succumbed to Spanish influenza that had killed up to 50 million people during the 1918-19 pandemic.

2. The current A/H1N1 version is a “highly unusual virus” never seen before that combines genetic material from North American human, avian, and swine flus and Eurasian swine flu.[1] Such a combination is unprecedented having never been found in pigs, birds, or people per The Associated Press, and likely improbable to have emerged naturally. When the fact that no close relatives of the current strain exist and IMV’s mission – to conduct virology research and training at a molecular level – is taken into account, creation through artificial genetic engineering offers the best explanation.

3. Retired Australian researcher Adrian Gibbs, who played a leading role in the development of Tamiflu®, a highly-effective anti-flu drug, theorized on May 12, 2009 that the new strain of A/H1N1 likely escaped from a laboratory setting because it exhibited characteristics “of having undergone ‘accelerated evolution’ such as what happens when flu viruses try to adapt to growth in eggs” during vaccine studies.[2] Although The World Health Organization (WHO) swiftly ruled out Mr. Gibbs’ theory a day later, it is implausible that sufficient research to ascertain a conclusion could be completed in only 24 hours.

4. When A/H1N1′s existence had been firmly established in the United States by May 10, 2009, Wisconsin and Illinois had nearly a third of the country’s cases. Since then Wisconsin has consistently led the nation despite its population of 5,627,967 based on July 2008 estimates versus the larger states – California, Texas, New York, Illinois and even Michigan with July 2008 populations of 36,755,666, 24,326,974, 19,490,297, 12,901,563 and 10,003,422, respectively. By June 12, 2009 when dispersion had set in, Wisconsin and Illinois still accounted for more than a quarter of U.S. cases. Demographically speaking this disproportionate caseload makes little sense. However, when Madison, WI is viewed as the point of origin, the two-State caseload provides incontrovertible evidence of the virus’ inception. When A/H1N1 likely escaped from IMV, it immediately impacted the city’s environs and nearby locales including Illinois (since a sizeable number of Wisconsinites commute to that state each day) before spreading to Mexico (likely transmitted by a U.S. national since Granja Carroll hog farms located in La Gloria where the first case of A/H1N1 is believed to have occurred, is a subsidiary of American-based Smithfield Foods), other parts of the United States and ultimately much of the rest of the world.

Centers For Disease Control (CDC) Bulletins:

5/10/2009: Wisconsin: 357 Cases (14.1% of the national caseload); Illinois: 466 Cases (18.4% of the national caseload)

6/12/2009: Wisconsin: 3008 Cases (16.8% of the national caseload); Illinois: 1983 Cases (11.1% of the national caseload)

5. To date the A/H1N1 2009 pandemic version of swine flu has not been found to be endemic in global pig stocks discounting natural mutation and initial pig to human transmission theories. Furthermore, none of the pig stocks in Wisconsin have tested positive for the novel A/H1N1 strain that currently afflicts the world.

6. Statements and actions point to prior knowledge. As early as April 25, 2009 when the new A/H1N1 strain was officially detected in only 3 states (11 cases), a top CDC official, Dr. Anne Schuchat stated, “We do not think we can contain the spread of this virus.” By April 28, 2009 Vice President Joseph Biden ruled out quarantining Mexico citing limited benefits since “the swine flu virus [had] already penetrated many states” (64 cases in 5 states). An immediate quarantine when news of the A/H1N1 outbreak in Mexico surfaced on April 23, 2009 likely was not implemented because the CDC and top U.S. government officials had already been alerted about the accidental escape from IMV and consequent unconfirmed and unreported infections. A quarantine made little sense since cases were rapidly evolving in the United States and because such a step would likely have drawn suspicion when such cases were subsequently confirmed and reported.

7. Samples of the new A/H1N1 virus were already present at the CDC prior to receipt of Mexican specimens. Per CDC virologist Ruben Donis in an interview conducted by Science Direct (published April 29, 2009) – the CDC had completed sequencing of the novel A/H1N1 strain two weeks earlier or by April 15, 2009 – three days before Mexican officials shipped swab samples to its Atlanta headquarters for testing.

Based on the compelling facts above, conclusive evidence exists that the outbreak of A/H1N1 swine flu that has led to the WHO’s first pandemic declaration in 41 years, was created synthetically and likely can be traced back to IMV’s lab in Madison, WI. As a result, the moderate risk based on A/H1N1′s characteristics and potential threat especially to a generation that has never endured a pandemic and those with pre-existing medical conditions (asthma and other respiratory disorders, diabetes, heart problems, immune deficiency disorders, and pregnancy, to name a few) whose immune systems are ill-prepared or equipped to recognize and combat the novel strain, respectively, must be taken seriously. At the writing of this article, this is not being done (e.g. The New York City Department of Health stated on its website as late as June 25, 2009 – “Most cases of influenza-like illness do not need to be tested for H1N1″ even though seasonal influenza has disappeared for the summer, failure to isolate suspected emergency room cases facilitating contagion, etc.). Continued failure to do so may result in between 1 million (based on a .25% mortality rate on existing WHO estimates that up to a third of the world’s population may be infected) to 25 million or more deaths since people will be treated much further into the illness (after serious complications have developed) and/or if the virus mutates into a more lethal form resulting in a 1+% mortality rate that is already being exhibited in Argentina, a country that has just entered the winter season.

__________

[1] Donald G. McNeil, Jr. In New Theory, Swine Flu Started in Asia, Not Mexico. The New York Times. 24 June 2009.

[2] Who, flu experts looking into claim swine flu evolved in lab. CBCNews.ca. 12 May 2009. 24 June 2009. http://www.cbc.ca/health/story/2009/05/ ... ution.html

Additional Source

Wayne Madsen. Hybrid A/H1N1 flu tied to genetic trigger for larger, mutated version. Online Journal. 24 June 2009. 24 June 2009. onlinejournal.com/artman/publish/article_4837.shtml

William Sutherland is a published poet and writer. He is the author of three books, “Poetry, Prayers & Haiku” (1999), “Russian Spring” (2003) and “Aaliyah Remembered: Her Life & The Person behind the Mystique” (2005) and has been published in poetry anthologies around the world. He has been featured in “Who’s Who in New Poets” (1996), “The International Who’s Who in Poetry” (2004), and is a member of the “International Poetry Hall of Fame.” He is also a contributor to Wikipedia, the number one online encyclopedia and has had an article featured in “Genetic Disorders” Greenhaven Press (2009).

Article Source: http://EzineArticles.com/?expert=William_Sutherland

http://hsibaltimore.com/2009/07/28/swine-flu-3/

[About three months ago, World Health Organization officials agreed to drop their use of the word “swine” and only refer to the flu as H1N1. Their reasoning: No swine, pigs, or hogs in any country in the world have been diagnosed with the illness. H1N1 does have elements of swine flu, but it also has elements of human and avian strains.]

=======================================================

Operating under the aegis of the MITRE Corporation, a federally-funded contracting entity, JASON scientists primarily met in the highly-secured Building 29 at 3550 General Atomics Court in San Diego. The location is the address of the Torrey Pines Institute. Funded by the Defense Advanced Research Projects Agency (DARPA), JASON also has links, according to distribution lists on JASON reports, to the CIA. The CIA maintains an element called the IC [Intelligence Community] JASON Program under the Chief Technical Officer. Traditionally, JASON self-selects its members from a number of academic disciplines. However, JASON almost lost its funding a few years ago, when, after issuing a report critical of the Bush administration’s ballistic missile defense program, DARPA attempted to force three new members, obviously political overseers, on to the JASON membership rolls. DARPA’s chief, Tony Tether, pulled funding for JASON, forcing the group for the first time since its inception in 1959 to look for another Pentagon sponsor. The ballistic missile defense program, also called Star Wars II, was a personal pet project of Secretary of Defense Donald Rumsfeld.

JASON survived when DARPA’s parent orgzniation, the Pentagon’s Directorate for Defense Research and Engineering (DDR&E), provided JASON with direct funding, an indication of the power enjoyed by the secretive JASON organization. JASON also has other federal government sponsors, including the Department of Energy.

JASON is also very much involved in issues of biological warfare.

JASON produced a report on Civilian Biodefense in January 2000, which was highly redacted when released. Even the names of the report’s authors and the information on four bio-warfare scenarios is completely blacked out, except for a discussion of a 1947 smallpox incident in Scenario Two. The report also states that the CIA’s Clandestine Measurement and Signatures Intelligence (MASINT) Operations Center and Counter-Proliferation Center were interested in biological weapons intelligence collection and signatures. A section of the report on “Managing Civilian Response” to a bio-war attack is also completely redacted, as is a section on domestic intelligence. A page on the anthrax threat references “psychological BW [biological weapons] warfare.”

The JASON report was completed almost two years before anthrax attacks all but suspended the work of Congress after 9/11 and saw the quick passage of the USAPATRIOT Act.

The JASON report also discusses the mining of medical data, including patient billing records, to find out if a disease outbreak has occurred and how far and what direction it is spreading by examining “spatiotemporal patterns,” including “averaging statistics for humans traveling globally.”

In fact, the JASON Civilian Biodefense report mirrors, in many respects, the analysis being currently conducted by medical intelligence (MEDINT) agencies around the world on the outbreak and spread of A/H1N1. And that begs the question: is A/H1N1, artificially-developed by U.S. government scientists, the real thing or a test run for something much worse?

===================================================

Niman has direct interaction and benefit from working with the vaccine manufacturers:

http://www.recombinomics.com/founder.html

Founder

Recombinomics, Inc. Founder and President, Henry L Niman earned a PhD at the University of Southern California in 1978. His dissertation focused on feline retroviral expression in tumors in domestic cats.

He took a postdoctoral position at Scripps Clinic and Research Foundation where he developed monoclonal antibody technology. He fused monoclonal antibody and synthetic peptide technologies and accepted a staff position at Scripps.

In 1982, he developed the flu monoclonal antibody, which is widely used throughout the pharmaceutical, biotech, and research industries in epitope tagging techniques. He also produced a broad panel of monoclonal antibodies against synthetic peptides of oncogenes and growth factors. These monoclonal antibodies were distributed worldwide to researchers by the National Cancer Institute. The antibodies identified novel related proteins which correlated with clinical parameters.

This technology was used to form ProgenX, a cancer diagnostic company that became Ligand Pharmaceuticals. Dr Niman subsequently identified protein expression patterns at the University of Pittsburgh. More recently, he became interested in infectious diseases while at Harvard Medical School. He then founded Recombinomics and discovered how viruses rapidly evolve. These latest findings are the subject of recent patent filings.

Patents

Recombinomics, Inc. Founder and President Henry L Niman, PhD has filed patents covering use of viral recombination in:

vaccine development
genetic stability monitoring
bio-informatics
basic applications of the genetics of rapid evolution

WO/2008/091659 Methods and Compositions for Predicting and Treating Drug Resistant Strains of Influenza Virus
PCT/US2008/00923

WO/2007/008605 Identifying and Predicting Influenza Variants and Uses Thereof
PCT/US2006/026354

WO/2006/033691 A2 Copy Choice Recombination and Uses Thereof
PCT/US2005/022873

Niman has been issued patents covering: coupling monoclonal antibody and synthetic peptide technologies protein expression profiling

Issued United States Patents
6,551,789 Process for characterizing a biological sample using patterns of oncogene expression
5,985,587 Polypeptide-induced monoclonal receptors to protein ligands
5,972,629 Method for characterizing antigenic reactivity of biological sample
5,786,178 Polypeptide-induced monoclonal receptors to protein ligands
5,733,738 Polypeptide-induced monoclonal receptors to protein ligands
5,591,587 Polypeptide-induced monoclonal receptors to protein ligands
5,563,247 Monoclonal antibodies to oncoproteins and methods of making monoclonal antibodies
5,030,565 Polypeptide-induced monoclonal receptors to protein ligands
5,015,571 Polypeptide-induced monoclonal receptors to protein ligands

H1N1 Pandemic Consulting

http://www.recombinomics.com/consulting.html

Recombinomics offers consulting on viral evolution and consequences, with emphasis on the H1N1 pandemic. Private and public influenza sequences are analyzed with patent pending technology to facilitate vaccine target selection and pandemic preparedness.

This analysis is supplemented with extensive tracking of H1N1 sequences worldwide including boots on the ground reports from key areas.

Predictions base on this dynamic analysis is of interest to vaccine manufacturers and pandemic planners in the public and private sectors.

====================================================

http://openvce.net/taxonomy/term/259?page=4

http://ezinearticles.com/?A-H1N1-Swine- ... id=2526695

http://www.maya.com/the-feed/friday-links-050109

Good morning, worker drones: This Week In Mayhem

Baxter: Product contained live bird flu virus
http://www.torontosun.com/news/canada/2 ... 60781.html

1918 Influenza: the Mother of All Pandemics

===================================================

This should be enough to paint a clear enough picture of LIEman, and his conflict-of-interest-ridden campaign of disinformation for profit.

It’s simple math, not rocket science.

This entry was posted on February 25, 2011 at 11:52 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

LikeBe the first to like this post.4 Responses to “Henry Niman, DARPA, MAYA, The MITRE Corporation, and Jeff Rense”

1.nwqfk said
March 1, 2011 at 9:21 pm
Here’s something you’ll find interesting…

Is Henry Niman the Mark Zuckerberg of ‘viral’ social networking?

Damn coincidences! Mark Zuckerberg was just getting Facebook off the ground at Harvard while a Harvard professor Named Niman had this to say about the ‘social networking’ of viral sequences back in the day of the over hyped SARS / bird flu.

Also, checkout the year Flutracker founded THEIR facebook. Gee what happened in 2009? Let me think about that one.
—————————————————————————————————————-

http://news.cnet.com/2100-1025-997045.h ... z1FPoJp5Gv

Perhaps the most impressive way in which technology has aided research into SARS is in helping to analyze the virus’ complete genetic code, which two teams announced over the weekend, and then making the results available. This week the CDC placed on its Web site the entire nucleotide sequence of the virus suspected to be responsible for SARS.

Henry Niman, a Harvard University instructor in surgery at Massachusetts General Hospital in Boston who has studied retroviruses, says the process normally would have taken researchers at least months. “The fact that the virus has been sequenced in two weeks by two groups–that’s pretty quick,” Niman said. “That’s unprecedented speed. You would probably not have had two groups going simultaneously if you didn’t have this information out there. The exchange of information has sped things up.”

Niman started two mailing lists this month to share SARS-related information with his colleagues: One for highlighting news reports and the other for scientific discussions.

“Putting together a list like this could have been done 10 years ago, but it would have been hard,” Niman said, because so few of his colleagues had e-mail accounts at the time. “The idea was to get the news out to a elected group rather than a broad group. If there was a Web site, it would probably reach more people than a listserv. But with a listserv it’s easier to focus it.”
—————————————————————————————————

FluTraker Facebook
Founded
2009
About
The web’s most comprehensive source for tracking the spread of swine flu.
Company Overview
Rhiza Labs and leading bioresearch firm Recombinomics have partnered to track the spread of the global swine flu pandemic with FluTracker.

FluTracker has been recognized as the Web’s most comprehensive and up-to-date resource for tracking suspected and confirmed cases of H1N1 swine flu.

FluTracker enables health officials and the general public to input new information, using simple online tools. The result is faster access to the most current information about the impact of outbreaks worldwide. (read less)
Rhiza Labs and leading bioresearch firm Recombinomics have partnered to track the spread of the global swine flu pandemic with FluTracker.

FluTracker has been recognized as the Web’s most comprehensive and up-to-date resource for tracking suspected and confirmed cases of H1N1 swine flu.

FluTracker enables health officials and the general public to input new information, using simple online tools. The result is faster access to the most current information about the impact of outbreaks worldwide. (read more)

Reply

labvirus said
March 1, 2011 at 9:27 pm
great stuff, you are on track like a bloodhound. please keep it coming.
god bless
alex

Reply

2.nwqfk said
February 27, 2011 at 9:06 pm
Will Dr. Niman run the Joint Rhiza Labs / Google booth at the AFCEA Homeland Security Conference?
http://rhiza.com/2011/02/23/afcea/

Rhiza CEO, Josh Knauer, will be giving two presentations at the AFCEA (Armed Forces Communications and Electronics Association) Homeland Security Conference at the Ronald Reagan International Trade Center in Washington, DC. Both presentations will take place in Booth #611 (Google/Onix Networking Booth) in the Atrium Exhibit Area.

10:30am – Booth #611 – Go Get Your Data: Learn how to effectively use mobile data to create “eyes on the ground” for prioritizing emergency response whether in a forest fire, a toxic spill or a hurricane using Google Earth and a new mobile data app from Rhiza that works across many types of smart phone operating systems.

2:00pm – Booth #611 – Asset Tracking for Homeland Security: Mapping physical and soft assets is challenging under the best of conditions, but a crucial challenge to Homeland Security agencies. Come learn about how new, emerging technologies are being used to make it easier to track assets at a local, state and federal level. Solutions from Google Earth and Rhiza will be highlighted, as well as best practices in the industry.
———————————————————————————————————-

Wouldn’t this be a great corporate / government partnership to run the next false flag pandemic Dr. Niman is so eager to declare at level 6?

Reply

3.Ted Kazinski said
February 26, 2011 at 7:26 pm
Dont forget folks that the/this H1N1 vaccine has a patent years before the alleged “novel” outbreak. Prima facie of criminal act/omissions.

Reply

http://labvirus.wordpress.com/2011/02/2 ... eff-rense/

_________________
www.twitter.com/hniman

For the above wackadoodlers on steroids, ProgenX had its initial labs and offices at General Atomics in San Diego in 1987.

_________________
www.twitter.com/hniman